CTLT — Catalent, Inc.

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Company fundamentals

MetricCached value
Price (USD)63.48
Market cap (USD)11,522,382,000
P/E-11.02
ROE (%)-25.32
Net profit margin (%)-23.74
Revenue growth (%)2.46
Dividend yield (%)0

Price last refreshed: .

Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.

About Catalent, Inc.

Available company fundamentals for CTLT in Drug Manufacturers - Specialty & Generic. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.